Literature DB >> 26846419

Preceding bronchial cutting for exposure of the pulmonary artery buried in scar tissue after chemoradiotherapy.

Hiroaki Nomori1, Yue Cong2, Hiroshi Sugimura2.   

Abstract

It is often difficult to expose the pulmonary artery buried in a scar tissue, especially in lung cancer patients that responded well to neoadjuvant chemoradiotherapy. Difficulty to access pulmonary artery branches may lead to potentially unnecessary pneumonectomy. To complete lobectomy in such cases, a technique with preceding bronchial cutting for exposure of the pulmonary artery is presented. After dissecting the pulmonary vein, the lobar bronchus is cut from the opposite side of the pulmonary artery with scissors. The back wall of the lobar bronchus is cut using a surgical knife from the luminal face, which can expose the pulmonary artery behind the bronchial stump and then complete lobectomy. Fourteen patients have been treated using the present technique, enabling complete resection by lobectomy (including sleeve lobectomy in 3 patients) without major bleeding. The present procedure can expose pulmonary artery buried in scar tissue, resulting in making the lobectomy safer.

Entities:  

Keywords:  Bronchial resection; Lung cancer; Neoadjuvant chemoradiotherapy

Mesh:

Year:  2016        PMID: 26846419     DOI: 10.1007/s11748-015-0618-8

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  4 in total

1.  Thoracoscopic lobectomy for lung cancer with a largely fused fissure.

Authors:  Hiroaki Nomori; Takashi Ohtsuka; Hirotoshi Horio; Tsuguo Naruke; Keiichi Suemasu
Journal:  Chest       Date:  2003-02       Impact factor: 9.410

2.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

3.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

Authors:  Kathy S Albain; R Suzanne Swann; Valerie W Rusch; Andrew T Turrisi; Frances A Shepherd; Colum Smith; Yuhchyau Chen; Robert B Livingston; Richard H Feins; David R Gandara; Willard A Fry; Gail Darling; David H Johnson; Mark R Green; Robert C Miller; Joanne Ley; Willliam T Sause; James D Cox
Journal:  Lancet       Date:  2009-07-24       Impact factor: 79.321

4.  Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.

Authors:  Godehard Friedel; Wilfried Budach; Juergen Dippon; Werner Spengler; Susanne Martina Eschmann; Christina Pfannenberg; Fawaz Al-Kamash; Thorsten Walles; Hermann Aebert; Thomas Kyriss; Stefanie Veit; Martin Kimmich; Michael Bamberg; Martin Kohlhaeufl; Volker Steger; Thomas Hehr
Journal:  J Clin Oncol       Date:  2010-01-25       Impact factor: 44.544

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.